• Individually Focused

    PGXL is a laboratory built to advance personalized medicine. We help physicians incorporate genetic understanding into their practices for the benefit of their patients. More

    Tubes 619

  • The Ability to Do More

    Researchers who need to add genetics to their trial design need a partner that brings more than testing capabilities to the table. PGXL’s scientists have participated in hundreds of trials, and no one knows more about incorporating genetics into clinical trials than we do. More

  • Single Cell Recovery and Characterization

    Genetic variation in tumors and circulating tumor cells can play a role in disease progression and treatment. PGXL’s exclusive single cell sorting and isolation provides molecular information at the level of individual cells. ¬†More.

    Silicon Bio Art 619

About PGxl

PGXL is an internationally recognized pioneer in the application of molecular diagnostics to pharmacogenetics and is the first laboratory to be CLIA-certified specifically for pharmacogenetics testing. The company was founded in 2005 by Dr. Roland Valdes, Jr., and Dr. Mark W. Linder, researchers who are among the worldwide thought leaders in the science underlying personalized medicine. Our scientists are leading the way in the incorporation of genetic information into the practice of medicine.

You can follow PGXL on Twitter @PGXLlabs

News

  • CAP Accreditation

    PGXL's expanded lab has been accredited by the College of American Pathologists (CAP) after an exacting period of preparation and ...

  • PGXL Software Cleared for Clinical Trials

    PGXL's PerMIT software has received regulatory clearance for a clinical trial involving up to 720 patients. PerMIT:Warfarin is a decision support software ...

  • Entrepreneur of the Year

    Ernst & Young recognizes PGXL's President, Dr. Roland Valdes Jr., as Entrepreneur of the Year. PGXL began as a scientific ...

  • PGXL Opens Anatomic Pathology Lab

    The first commercial samples are going through our new AP lab today. It's going to be small volume for a ...

PGxl Blog